ATA188
ATA188-MS-101
Phase 2 mab terminated
Quick answer
ATA188 for Primary Progressive Multiple Sclerosis is a Phase 2 program (mab) at Atara Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atara Biotherapeutics
- Indication
- Primary Progressive Multiple Sclerosis
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated